Toggle navigation
Home
Topics
Topics
Clinical Systems
Clinical Systems
Clinical Systems
Clinical Systems
Medical Device Packaging
Obstetrics and Gynecology
Obstetrics and Gynecology
Oncology Systems
Specialties
Specialties
Specialties
Specialties
Sports Medicine
Transformation
Transformation
Transformation
Transformation
Ultrasound Devices
CXO Insights
Vendor Viewpoint
News
Conferences
Newsletter
CXO Awards
About Us
US
US
EUROPE
APAC
Toggle navigation
Obstetrics and Gynecology
ENT Devices
Medical Imaging Systems
Dental Care Devices
Sanitization Products and Equipment
Patient Monitoring Devices Latam
Orthopedic Devices and instruments Latam
Neurology Devices Latam
In Vitro Diagnostics Latam
Endoscopy Latam
Dental Care Devies Latam
Cardio Vascular Devices Latam
Patient Monitoring Devices
Dermatology Care
ENT Devices
FemTech
Regenerative Medicine
Medical Equipment
Medical Imaging Systems
Patient Monitoring Devices
Regenerative Medicine
Cancer Care
Medical Equipment
Medical Device Design and Development
Medical Device Regulatory and Compliance
Medical Device Design and Development Latam
Specialties
Clinical Systems
Transformation
Clinical Systems Latam
Endoscopy
Specialties Latam
Clinical Systems
Transformation Latam
Specialties
Transformation
Transformation
Specialties
Medical Device Packaging
Clinical Systems
Vein Detection
Nephrology and Urology
Medical Aesthetics
Respiratory Care
Medical Device Design and Development
Neurology Devices
Endoscopy
Medical Equipment
Obstetrics and Gynecology
Surgical Devices and Instruments
Sports Medicine
Drug Delivery Solutions
Cardiovascular Devices
In Vitro Diagnostics
Medical Aesthetics
Patient Monitoring Devices
Dermatology Care
ENT Devices
Ultrasound Devices
Physiotherapy and Pain Management
Orthopedic Devices and instruments
Biomechanics
Mobility Devices and Aids
Oncology Systems
Chronic and Long Term Care
Dental Care Devices
Orthopedic Devices and instruments
In Vitro Diagnostic
Mobility Devices and Aids
Surgical Devices and Instruments
Drug Delivery Solutions
Physiotherapy and Pain Management
Medtech Startups
Cardio Vascular Devices
Surgical Devices and Instruments
Cardiovascular Devices
Physiotherapy and Pain Management
Drug Delivery Solutions
Medical Device Consulting
Orthopedic
Respiratory Devices
Medical Device Design and Development
Endoscopy
Medical Imaging Systems
In Vitro Diagnostics
Infection Control Solutions Canada
Physiotherapy and Pain Management Latam
Surgical Devices Latam
Regenerative Medicine
Medical Equipment
Cancer Care
Medical Imaging Systems
Regenerative Medicine
Nephrology and Urology
Medical Equipment
MORE
OCTOBER 20239The advantage of PET/CT is the ability to see the metabolically active cancer cellsPositron Emission Tomography with CT (PET/CT)Positron emission tomography generates images of the metabolic activities of cancer cells in the patient. This is done by intravenous injection of sugar that is bounded to a radioactive tracer (18-fluorodeoxyglucose) to the patient. Once the patient is positioned inside the tomography unit, the sugar is metabolically absorbed by the cancer cells, and the radioactive tracers (annihilation radiation) are detected by the ring of detectors located inside the tomography unit. The end result is the volumetric images of metabolically active cancer cells fused with CT images of the patient, hence called PET/CT. The reason why image fusion of CT is necessary is that PET itself does not provide adequate information about the physical anatomy of the patient to properly identify and locate the metabolically active cancer cells within the patient. By fusing the CT images with the PET images, the clinician can clearly identify and orient where the metabolically active cancer cells are located with respect to the patient's anatomy. The advantage of PET/CT is the ability to see the metabolically active cancer cells. Images like CT and MRI may show the solitary mass, but the mass may not necessarily be an active cancer (for example, it can be fibrotic tissue that looks similar to the solid tumor in CT images). PET/CT can provide supplemental information about the metabolic activity of the cancer cells. Typically, PET/CT is used in lung cancer and metastatic cancers to supplement the CT images in radiation therapyImaging Modality Integrated within Linear AcceleratorBecause the localization of cancers at the time of treatment is critical to the treatment outcome, multiple imaging modalities have been integrated with a medical linear accelerator. A medical linear accelerator is a machine that generates high energy X-rays that can deliver radiation with pinpoint accuracy to the target, provided that the target inside the patient can be localized. For this reason, there has been a significant push for the integration of various volumetric imaging modalities with linear accelerators. The most common integration is with cone beam CT. MRI has also been integrated into the linear accelerator in order to exploit the benefits of soft tissue contrast. Most recently, the integration of PET has been introduced to the market. By integrating various imaging modalities with the treatment machines, clinicians are able to better localize the tumor at the time of the treatment. The advantage of the integration is the ability to increase the radiation dose to the cancer while minimizing the dose to critical structures. IMAGING APPLICATION IN RADIATION THERAPY
<
Page 8
|
Page 10
>